Cherry Tree Wealth Management, LLC Gilead Sciences, Inc. Transaction History
Cherry Tree Wealth Management, LLC
- $404 Billion
- Q4 2024
A detailed history of Cherry Tree Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cherry Tree Wealth Management, LLC holds 25 shares of GILD stock, worth $2,649. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 9
177.78%
Holding current value
$2,649
Previous $755,000
205.96%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,045Shares Held
1BCall Options Held
10MPut Options Held
9.05M-
Black Rock Inc. New York, NY121MShares$12.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.2 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.6 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.2MShares$6.38 Billion0.21% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.14 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $133B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...